✦ LIBER ✦

Interstitial thermoradiotherapy of brain tumors: A phase I clinical trial

✍ Scribed by B. Stea; T. Cetas; W. Lutz; B. Lulu; A. Shatter; K. Rossman; E. Obbens; N. Guthkolch; R. Iacono; D. Shimm; J.R. Cassady

Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 138 KB
Volume: 17
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(89)90746-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II clinical trial of idarubicin

A phase II clinical trial of idarubicin administered to children with relapsed brain tumors

✍ Carola A. S. Arndt; Mark D. Krailo; Laurel Steinherz; Berndt Scheithauer; W. Liu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

A phase I clinical trial of recombinant

A phase I clinical trial of recombinant human tumor necrosis factor

✍ Edward T. Creagan; John S. Kovach; Charles G. Moertel; Stephen Frytak; Larry K. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

125Iodine interstitial brachytherapy for

125Iodine interstitial brachytherapy for primary malignant brain tumors. a phase I–II study

✍ D.C. Wright; P. Findlay; U. Rosenow; K. Orr; R. Miller; F. Harrington; T. Kinsel 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Phase I clinical trial of recombinant hu

Phase I clinical trial of recombinant human tumor necrosis factor

✍ Patrick J. Creaven; John E. Plager; Sherry Dupere; Robert P. Huben; Hiroshi Taki 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 566 KB

A phase i clinical trial of didemnin B

✍ James A. Stewart; Jane B. Low; John D. Roberts; Alton Blow 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 2 views

Phase I clinical trial of weekly combine

Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors

✍ Jacob Lokich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I and feasibility study of combined docetaxel (D) plus paclitaxel (P) was undertaken to determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) for each analogue delivered concomitantly on a weekly schedule. ## METHODS. Patients were accrued in 3-6 patient cohorts to P